Ginkgo Bioworks Holdings Inc. DNA
$8.23
โผ -1.38% 24H
About
Ginkgo Bioworks Holdings Inc. is a biotechnology company that operates as a platform for cell programming, delivering flexible, end-to-end services to address challenges across diverse markets including food and agriculture, pharmaceuticals, industrial and specialty chemicals. It organizes its operations into two primaโฆ
SectorHealthcare
ExchangeNYSE
IndustryBiotechnology
CountryUnited States
Employees485
TickerDNA
Statistics
Market Cap$479.0M
Revenue (TTM)$170.2M
Net Income-$312.8M
Net Margin-183.8%
EPS$-5.64
P/E-1.40
P/S3.40
P/B1.10
EV/EBITDA-2.10
ROE-56.0%
Dividend Yieldโ
Price$8.23
Data: Twelve Data ยท Revenue = mcap / P/S